Found: 14
Select item for more details and to access through your institution.
The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1157, doi. 10.1111/dom.15425
- By:
- Publication type:
- Article
A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes.
- Published in:
- Pediatric Diabetes, 2022, v. 23, n. 6, p. 641, doi. 10.1111/pedi.13343
- By:
- Publication type:
- Article
Organokines, Sarcopenia, and Metabolic Repercussions: The Vicious Cycle and the Interplay with Exercise.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13452, doi. 10.3390/ijms232113452
- By:
- Publication type:
- Article
GLP-1a: Going beyond Traditional Use.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 739, doi. 10.3390/ijms23020739
- By:
- Publication type:
- Article
Investigating the Incidence of Dyslipidemia among Brazilian Children and Adolescents Diagnosed with Type 1 Diabetes Mellitus: A Cross-Sectional Study.
- Published in:
- Diseases, 2024, v. 12, n. 3, p. 45, doi. 10.3390/diseases12030045
- By:
- Publication type:
- Article
Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Obesity, more common now in young patients, adds to the burden of cardiorenal syndrome.
- Published in:
- Nephrology News & Issues, 2023, v. 37, n. 4, p. 5
- By:
- Publication type:
- Article
Empagliflozin lowers kidney disease progression, cardiovascular death in patients with CKD.
- Published in:
- Nephrology News & Issues, 2022, v. 36, n. 12, p. 26
- By:
- Publication type:
- Article
New drug therapy will change the CKD landscape.
- Published in:
- Nephrology News & Issues, 2021, v. 35, n. 7, p. 3
- By:
- Publication type:
- Article
Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways.
- Published in:
- Biology (2079-7737), 2024, v. 13, n. 7, p. 519, doi. 10.3390/biology13070519
- By:
- Publication type:
- Article
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2022, v. 38, n. 3, p. 1, doi. 10.1002/dmrr.3502
- By:
- Publication type:
- Article
Review of glucagon‐like peptide‐1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.
- Published in:
- Journal of Diabetes, 2019, v. 11, n. 12, p. 938, doi. 10.1111/1753-0407.12969
- By:
- Publication type:
- Article
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Long-Term Efficacy and Safety of Linagliptinin Patients With Type 2 Diabetes and Severe Renal Impairment.
- Published in:
- Diabetes Care, 2013, v. 36, n. 2, p. 237, doi. 10.2337/dc12-0706
- By:
- Publication type:
- Article